![Rahul Ballal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/08/2026
Rahul D.
Ballal was the founder of TSS Redmond LLC, founded in 2002, where the title held was Chief Executive Officer in 2002.
Dr. Ballal is also the founder of Redmind LLC..
Dr. Ballal currently serves as Chief Executive Officer & Director at Mediar Therapeutics, Inc. Dr. Ballal is an Independent Director at Agios Pharmaceuticals, Inc. since 2022.
Dr. Ballal is a Director at InduPro, Inc. Dr. Ballal is an Independent Director at Enliven Therapeutics, Inc. since 2023.
Dr. Ballal is a Director at Vaderis Therapeutics AG.
Former positions include President, Chief Executive Officer & Director at Imara, Inc., Vice President-Business Development at Flexion Therapeutics, Inc. from 2015 to 2016, Entrepreneur in Residence at Versant Venture Management LLC, and Chief Business Officer at Northern Biologics, Inc. from 2016 to 2018.
Education includes undergraduate studies at Brown University, graduate studies at The Johns Hopkins University, and a doctorate from Georgetown University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 22.341 ( 0,03% ) | 1 M $ | 31/08/2026 | |
| 18/06/2026 | 15.230 ( 0,03% ) | 512 946 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 11/08/2022 |
| ENLIVEN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/02/2023 |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Amministratore Delegato | 01/02/2023 |
Vaderis Therapeutics AG
 Vaderis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops targeted therapies for rare diseases associated with vascular malformations | Direttore/Membro del Consiglio | - |
InduPro, Inc.
 InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Corporate Officer/Principal | 01/06/2018 |
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2016 |
TSS Redmond LLC
 TSS Redmond LLC Packaged SoftwareTechnology Services Provides end-to-end share point, desktop and office 365 solutions | Amministratore Delegato | 01/06/2002 |
Redmind LLC | Amministratore Delegato | - |
| ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TSS Redmond LLC
TSS Redmond LLC Packaged SoftwareTechnology Services Provides end-to-end share point, desktop and office 365 solutions | Technology Services |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Health Services |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Health Technology |
Vaderis Therapeutics AG
Vaderis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops targeted therapies for rare diseases associated with vascular malformations | Health Technology |
Redmind LLC | |
InduPro, Inc.
InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies | Commercial Services |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
